NTI 1.37% 7.2¢ neurotech international limited

The more I look at our results from our initial ASD and Pandas...

  1. 714 Posts.
    lightbulb Created with Sketch. 154
    The more I look at our results from our initial ASD and Pandas Pans trials :
    1)ASD
    https://announcements.asx.com.au/asxpdf/20221026/pdf/45gs1jm8ync5k5.pdf
    2)Pandas Pans
    https://announcements.asx.com.au/asxpdf/20231006/pdf/05vrp7vzjjykl6.pdf

    Our latest Presentation
    https://announcements.asx.com.au/asxpdf/20231122/pdf/05xmddn5kv3nv0.pdf


    And when compared to the latest Phelan McDermind syndrome results and also Retts from Neuron (Neu) -- which I believe we look to have better outcomes in both ASD and Pandas Pans in comparisons about side effects, safety, CGI classification and Vineland assessment.

    While Neuron has gone down the more recognised path with synthetic drugs we have a more difficult path and process with a full plant extract.
    If we can show the market a way forward to the prescription only market, I believe we will be on a multi billion dollar company.

    The Dream
    $80m to $800m this year
    Or maybe Inevitable
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
-0.001(1.37%)
Mkt cap ! $74.26M
Open High Low Value Volume
7.4¢ 7.4¢ 7.2¢ $15.96K 219.2K

Buyers (Bids)

No. Vol. Price($)
1 2401 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 35137 2
View Market Depth
Last trade - 14.25pm 30/05/2024 (20 minute delay) ?
Last
7.2¢
  Change
-0.001 ( 1.37 %)
Open High Low Volume
7.5¢ 7.5¢ 7.2¢ 15965
Last updated 11.29am 30/05/2024 ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.